Efficacy & Safety of Inhaled Insulin in Type 1 Diabetes

NCT ID: NCT00308308

Last Updated: 2014-10-16

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

589 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-02-28

Study Completion Date

2008-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine the safety and efficacy of inhaled insulin in the treatment of type 1 diabetes

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes, Type I

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Technosphere Insulin

Group Type EXPERIMENTAL

Technosphere Insulin

Intervention Type DRUG

Inhalation, 15U/30U

2

Rapid-acting analogue insulin plus basal insulin glargine

Group Type ACTIVE_COMPARATOR

Active comparator

Intervention Type DRUG

sc injectable insulin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Technosphere Insulin

Inhalation, 15U/30U

Intervention Type DRUG

Active comparator

sc injectable insulin

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of type 1 diabetes for at least 1 year
* Nonsmokers for prior 6 months
* BMI less than or equal to 35kg/m2
* HbA1c \> or = 7% and \< or = 11%
* Serum creatinine \< or = 1.8 mg/dL in female subjects and \< or = 2.0 mg/dL in male subjects
* FEV1 \> or = 70% of predicted, DLco \> or = 70% , TLC \> or = 80% predicted
* Maintenance of a treatment regimen of insulin less than or equal to 1.4 iu/kg/day
* Urine cotinine \< or = 100 ng/mL

Exclusion Criteria

* History of chronic obstructive pulmonary disease, asthma, any other clinically significant pulmonary disease confirmed by documented history, pulmonary function testing or radiologic findings
* Evidence of severe complications of diabetes
* Aminotransferase and/or alanine aminotransferase \> than 3 times the upper limit of normal
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mannkind Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Coastal Clinical Research Inc

Mobile, Alabama, United States

Site Status

Radiant Research (Phoenix)

Chandler, Arizona, United States

Site Status

International Clinical Research Network

Chula Vista, California, United States

Site Status

Family Medical Center

Foothill Ranch, California, United States

Site Status

Diabetes/Lipid Management and Research Center

Huntington Beach, California, United States

Site Status

South Bay Clinical Research

Inglewood, California, United States

Site Status

Radiant Research

San Diego, California, United States

Site Status

Coastal Biomedical Research Inc

Santa Monica, California, United States

Site Status

Diabetes Research Center

Tustin, California, United States

Site Status

International Research Associates LLC

Miami, Florida, United States

Site Status

Laureate Clinical Research Group

Atlanta, Georgia, United States

Site Status

Atlanta Pharmaceutical Research Center

Dunwoody, Georgia, United States

Site Status

North Atlanta Endocrinology & Diabetes PC

Lawrenceville, Georgia, United States

Site Status

Endocrine Research Solutions, Inc.

Roswell, Georgia, United States

Site Status

John H Stoger Jr Hospital of Cook County

Chicago, Illinois, United States

Site Status

Clintell Inc

Skokie, Illinois, United States

Site Status

Medical Research of Louisiana

Metairie, Louisiana, United States

Site Status

Oschner Clinic Foundation

New Orleans, Louisiana, United States

Site Status

James A Dicke MDPA

Towson, Maryland, United States

Site Status

Wayne State University

Detroit, Michigan, United States

Site Status

Hurley Medical Center

Flint, Michigan, United States

Site Status

Michigan Institute of Medicine

Livonia, Michigan, United States

Site Status

KMED Research

Saint Clair Shores, Michigan, United States

Site Status

Radiant Research Inc (Minneapolis)

Edina, Minnesota, United States

Site Status

International Diabetes Center

Minneapolis, Minnesota, United States

Site Status

Center for Urologic Clinical Trials University of Minnesota

Minneapolis, Minnesota, United States

Site Status

Amin Radparvar's Private Practice

City of Saint Peters, Missouri, United States

Site Status

Healthcare Research

Florissant, Missouri, United States

Site Status

MedEx Healthcare Research Inc(009)

St Louis, Missouri, United States

Site Status

Billings Clinic Research Division

Billings, Montana, United States

Site Status

Creighton Diabetes Center

Omaha, Nebraska, United States

Site Status

University of New Mexico HCS

Albuquerque, New Mexico, United States

Site Status

Winthrop University Hospital

Mineola, New York, United States

Site Status

North Shore Diabetes and Endocrine Associates

New Hyde Park, New York, United States

Site Status

University of Physicians Group Endocrine Division

Staten Island, New York, United States

Site Status

Endocrine Research - Physician's East PA

Greenville, North Carolina, United States

Site Status

Cleveland Clinic Foundation

Cleveland, Ohio, United States

Site Status

Providence Health Partners - Center of Clinical Research

Dayton, Ohio, United States

Site Status

Portland Diabetes & Endocrinology Center

Portland, Oregon, United States

Site Status

Legacy Clinical Research

Portland, Oregon, United States

Site Status

Covance CRU Inc.

Portland, Oregon, United States

Site Status

Pennsylvania Research Institute

Bensalem, Pennsylvania, United States

Site Status

Southeastern Research Associates Inc

Williamston, South Carolina, United States

Site Status

AM Diabetes and Endocrinology Center

Bartlett, Tennessee, United States

Site Status

The Endocrine Clinic

Memphis, Tennessee, United States

Site Status

Israel Hartman MD

Arlington, Texas, United States

Site Status

Dallas Diabetes & Endocrine Center

Dallas, Texas, United States

Site Status

Radiant Research Dallas-North

Dallas, Texas, United States

Site Status

Baylor Endocrine Center

Dallas, Texas, United States

Site Status

University of Texas Southwestern Medical Center

Dallas, Texas, United States

Site Status

Spuhler Medical Associates

Friendswood, Texas, United States

Site Status

Quality Assurance Research Center (900)

San Antonio, Texas, United States

Site Status

Diabetes & Glandular Disease Research Assoc PA

San Antonio, Texas, United States

Site Status

SAM Clinical Research Center

San Antonio, Texas, United States

Site Status

Edward Bali MD PA

Seguin, Texas, United States

Site Status

Radiant Research Salt Lake City

Salt Lake City, Utah, United States

Site Status

Salt Lake Research

Salt Lake City, Utah, United States

Site Status

Sentara Medical Group

Virginia Beach, Virginia, United States

Site Status

Larry D Stonesifer MD Inc PS

Federal Way, Washington, United States

Site Status

Cedar Research

Tacoma, Washington, United States

Site Status

Liberty Research Center

Tacoma, Washington, United States

Site Status

Hospital Interzonal de Agudos Pedro Fiorito

Avellaneda, Buenos Aires, Argentina

Site Status

Centro Endocrinologic Tiempo

Buenos Aires, , Argentina

Site Status

Hospital Italiano de Buenos Aires

Buenos Aires, , Argentina

Site Status

Hospital Durand /Buenos Aires

Buenos Aires, , Argentina

Site Status

Hospital Gral De Agudos Dr. Teodoro Alvarez

Buenos Aires, , Argentina

Site Status

Cons Asoc de Endocrinologia

Buenos Aires, , Argentina

Site Status

Centro Medico Dra De Salvo

Buenos Aires, , Argentina

Site Status

CIMeL

Buenos Aires, , Argentina

Site Status

Hospital de Clinicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

Hospital Sao Lucas da PUCRS

Porto Alegre, Rio Grande do Sul, Brazil

Site Status

CPClin-Centro de Pesquisas Clinicas

São Paulo, São Paulo, Brazil

Site Status

Universidade Estabual de Maringa

Maringa Parana, , Brazil

Site Status

Nucleo de Medicina Integrada

Mogi das Cruzes, , Brazil

Site Status

Instituto Estadual De Diabetes e Endocrinologia Luis Capriglione

Rio de Janeiro, , Brazil

Site Status

Ccbr Brasil Centro de Analises e Pesquisas Clinicas Ltda

Rio de Janeiro, , Brazil

Site Status

Hospital Guilherme Alvaro

Santos, , Brazil

Site Status

Centro de Diabetes/UNIFESP-EPM

São Paulo, , Brazil

Site Status

Blumenau Servicos Medicos S/C Ltda

São Paulo, , Brazil

Site Status

Instituto de Pesquisa Clinica e Medicina Avancada

São Paulo, , Brazil

Site Status

Lifestyle Metabolism Center

Oakville, Ontario, Canada

Site Status

Lifestyle Metabolism Center

Thornhill, Ontario, Canada

Site Status

Lifestyle Metabolism Center

Toronto, Ontario, Canada

Site Status

Windsor Professional Research

Windsor, Ontario, Canada

Site Status

Hospital del Salvador

Santiago, Santiago Metropolitan, Chile

Site Status

Hospital San Jose

Santiago, , Chile

Site Status

Hospital Clinico Pontificia Universidad (009)Catolica de Chile

Santiago, , Chile

Site Status

Hospital Padre Alberto Hurtado

Santiago, , Chile

Site Status

Hospital San Borja ArriaranUniversidad de Chile

Santiago, , Chile

Site Status

Instituto de Informacion de Tramiento y Educacion en Salud

Santiago, , Chile

Site Status

Instituto Mexicano de Investigacion

Mexico City, Durango, Mexico

Site Status

Hospital Santa Engracia-CIMA

Garza García, , Mexico

Site Status

Centro de Estudios en Diabetes

Mexico City, , Mexico

Site Status

Hospital General de Mexico Servicio EndocrinologiaJefe Del Servicio

Mexico City, , Mexico

Site Status

Hospital OCA-MIRC (009)

Monterrey, , Mexico

Site Status

NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny

Bialystok, POL, Poland

Site Status

Katedra I Klinika Chorob Metabolicznych Collegium Medicum Uniwersytety Jagiellonskiego

Krakow, POL, Poland

Site Status

Instytut Centrum Zdrowia (009) Matki Polki

Lodz, POL, Poland

Site Status

Szpital Kolejowy im Dr w Roeflera(009) Oddzial Gastorenterologii

Pruszków, POL, Poland

Site Status

Oddzial Chorob Wewnetrznych (009 Endokrynologii I Diabetologii Szpitala Wojewodzkiego

Bialystok, , Poland

Site Status

Oddzial Kliniczny Diabetologii (009) Kliniczny nr 1 im Norberta Barlickiego Uniwersytety Meycznego

Lodz, , Poland

Site Status

NZOZ Diabetologiczna Poradnia Specjalistyczna

Warsaw, , Poland

Site Status

NHI Kemerovo Regional Clinical Hospital

Kemerovo, RUS, Russia

Site Status

NI Principal Military Clinical Hospital n a academician N.N. Burdenko of the Ministry of Defense

Moscow, RUS, Russia

Site Status

NEI HPE Moscow State University of Medicine and Dentistry of FAHSD City Clinical Hospital #70

Moscow, RUS, Russia

Site Status

Moscow City Clinical Hospital # 13

Moscow, RUS, Russia

Site Status

SEI HPE Moscow Medical Academy IM Sechenov of Roszdrav Clinic of Endocrinology

Moscow, RUS, Russia

Site Status

SI Internal Affairs of Moscow- Clinical Hospital

Moscow, RUS, Russia

Site Status

RAAMS Endocrinology and Diabetology Department

Moscow, RUS, Russia

Site Status

SIH of Moscow City Clinical Hopsital #81Endocrinology and Diabetology

Moscow, RUS, Russia

Site Status

St Petersburg NHI City Polytclinic #77 City Diabetological Center #4

Saint Petersburg, RUS, Russia

Site Status

Central Medical Sanitary Unit #122

Saint Petersburg, RUS, Russia

Site Status

St Petersburg NHI Municipal Multi-Speciality Hospital # 2

Saint Petersburg, RUS, Russia

Site Status

Pavlov State Medical Univ of St Petersburg

Saint Petersburg, RUS, Russia

Site Status

MHI Clinical Hospital for Emergency Care na NV Soloviev

Yaroslavl, RUS, Russia

Site Status

MCHI Medical Sanitary Unit of Novo-Yaroslavsky Oil Refining Plant

Yaroslavl, RUS, Russia

Site Status

NHI Yaroslavl Regional Clinical Hospital

Yaroslavl, RUS, Russia

Site Status

City Clinical Hospital # 61

Moscow, , Russia

Site Status

Russian Scientific Center of Restoration Medicine & Balneology

Moscow, , Russia

Site Status

Complejo Hospitalario Nuestra Senora de Valme

Seville, Andalusia, Spain

Site Status

Hospital del Mar

Barcelona, , Spain

Site Status

Hospital Ramon y Cajal

Madrid, , Spain

Site Status

Complejo Hospitalario Virgen del Rocio

Seville, , Spain

Site Status

Hospital Virgen Macarena (policlinico) 2ª planta Servicio de Endocrinologia y Nutricion

Seville, , Spain

Site Status

Birchwood Surgery

Letchworth Garden City, Herts, United Kingdom

Site Status

Lister Hospital

Stevenage, Herts, United Kingdom

Site Status

Sandwell General Hospital

Lyndon, West Bromwich, United Kingdom

Site Status

Guy's & St Thomas Hospital

London, , United Kingdom

Site Status

Yaxley Group Practice

Peterborough, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Argentina Brazil Canada Chile Mexico Poland Russia Spain United Kingdom

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MKC-TI-009

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.